---
category: listing
circular_id: 52415e309f036ef3
date: '2025-08-26'
description: NSE notification for listing of 1,398,463 equity shares of Kilitch Drugs
  (India) Limited allotted under rights issue, effective August 28, 2025.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML69876.pdf
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine listing notification for rights issue shares of single company
  with limited market impact
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML69876.pdf
processing:
  attempts: 1
  content_hash: 08c68b97142b9299
  processed_at: '2025-08-26T18:44:38.405980'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-26T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML69876.pdf
severity: low
source: nse
stocks:
- KILITCH
tags:
- listing
- rights-issue
- equity-shares
- kilitch-drugs
- trading
title: Listing of further issues of securities - Kilitch Drugs (India) Limited rights
  issue
---

## Summary

NSE has notified the listing of additional equity shares of Kilitch Drugs (India) Limited issued under a rights issue. The shares will be admitted to trading on the Capital Market segment with effect from August 28, 2025.

## Key Points

- Company: Kilitch Drugs (India) Limited (Symbol: KILITCH)
- Number of shares: 1,398,463 equity shares
- Face value: Rs. 10 per share
- Issue price: Rs. 357 per share
- Date of allotment: August 25, 2025
- ISIN: INE729D01010
- Market lot: 1 share
- Distinctive number range: 16082320 to 17480782

## Regulatory Changes

No regulatory changes introduced. This is a routine listing notification following existing regulations.

## Compliance Requirements

- Trading members must use the designated security code (KILITCH) for trading
- Trading must be conducted in the specified lot size of 1 share
- Securities are identified by designated codes on the trading system

## Important Dates

- Circular effective date: August 28, 2025
- Date of allotment: August 25, 2025
- Trading commencement: August 28, 2025

## Impact Assessment

Minimal market impact as this is a routine listing of rights issue shares for a single company. The shares are pari passu with existing equity shares and have no lock-in restrictions. Currently, shares are credited under temporary ISIN in dematerialized mode as per SEBI guidelines for additional issues.